Sectoral Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Sectoral Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-63,150	Closed	-$9.2M	–	122
2022 Q2	$9.2M	Sell	63,150 -42,700	-40%	-$5.45M	1.85%	14
2022 Q1	$12.6M	Buy	+105,850	New	+$13.2M	2.23%	10
2020 Q3	–	Sell	-7,200	Closed	-$526K	–	208
2020 Q2	$526K	Buy	+7,200	New	+$383K	0.05%	137
2019 Q2	–	Sell	-3,900	Closed	-$201K	–	112
2019 Q1	$201K	Buy	+3,900	New	+$168K	0.02%	88

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sectoral Asset Management's BHVN Position: Q3 2022 in Review

Sectoral Asset Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 63,150 shares — an estimated $9.2M sold.

Sectoral Asset Management first reported a position in BHVN in Q1 2019 and held it in 4 quarters. The position peaked at $12.6M in Q1 2022. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

Sectoral Asset Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
Sectoral Asset Management sold 63,150 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $9.2M.
Sectoral Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and held it in 4 quarters.
Sectoral Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $12.6M in Q1 2022.
240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Sectoral Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.